Sporadic MTC typically presents in the fourth to sixth decades, with somatic RET variants as prevalent oncogenes (40-50% in unselected cohorts, up to 85% in advanced cases) [5, 7-12]. The gene discussed is RET; the disease is medullary thyroid gland carcinoma.